Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $172.39 in the prior trading day, Tenet Healthcare Corp (NYSE: THC) closed at $171.4, down -0.57%. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 0.82 million shares were traded. THC stock price reached its highest trading level at $174.04 during the session, while it also had its lowest trading level at $170.31.
Ratios:
Our goal is to gain a better understanding of THC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.28. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 3.15 whereas as Long-Term Debt/Eq ratio is at 3.13.
On April 15, 2025, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $137.
On March 26, 2025, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $165.Morgan Stanley initiated its Overweight rating on March 26, 2025, with a $165 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when FISHER RICHARD W sold 836 shares for $173.16 per share. The transaction valued at 144,762 led to the insider holds 11,292 shares of the business.
Arbour Paola M sold 7,738 shares of THC for $1,338,674 on Jun 05 ’25. The EVP, Chief Information Officer now owns 20,110 shares after completing the transaction at $173.00 per share. On Jun 05 ’25, another insider, Arbour Paola M, who serves as the Officer of the company, bought 7,738 shares for $173.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 16012445696 and an Enterprise Value of 30990759936. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.33, and their Forward P/E ratio for the next fiscal year is 12.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.78 while its Price-to-Book (P/B) ratio in mrq is 3.81. Its current Enterprise Value per Revenue stands at 1.51 whereas that against EBITDA is 7.388.
Stock Price History:
The Beta on a monthly basis for THC is 1.54, which has changed by 0.28168702 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $178.76, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is 5.22%, while the 200-Day Moving Average is calculated to be 17.73%.
Shares Statistics:
The stock has traded on average 1.63M shares per day over the past 3-months and 1276670 shares per day over the last 10 days, according to various share statistics. A total of 92.89M shares are outstanding, with a floating share count of 91.17M. Insiders hold about 1.84% of the company’s shares, while institutions hold 96.70% stake in the company. Shares short for THC as of 1749772800 were 4133917 with a Short Ratio of 2.54, compared to 1747267200 on 2381955. Therefore, it implies a Short% of Shares Outstanding of 4133917 and a Short% of Float of 5.88.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 952905600. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 18.0 analysts. The consensus estimate for the next quarter is $2.57, with high estimates of $3.04 and low estimates of $2.28.
Analysts are recommending an EPS of between $14.01 and $12.23 for the fiscal current year, implying an average EPS of $12.84. EPS for the following year is $13.72, with 20.0 analysts recommending between $15.62 and $11.58.
Revenue Estimates
16 analysts predict $5.16B in revenue for the current quarter. It ranges from a high estimate of $5.22B to a low estimate of $5.1B. As of the current estimate, Tenet Healthcare Corp’s year-ago sales were $5.1BFor the next quarter, 16 analysts are estimating revenue of $5.17B. There is a high estimate of $5.24B for the next quarter, whereas the lowest estimate is $5.1B.
A total of 20 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.22B, while the lowest revenue estimate was $20.68B, resulting in an average revenue estimate of $20.92B. In the same quarter a year ago, actual revenue was $20.66BBased on 20 analysts’ estimates, the company’s revenue will be $21.95B in the next fiscal year. The high estimate is $22.41B and the low estimate is $21.49B.
